ATE397064T1 - Genomische und vollständige cdna sequenzen von menschlichem adipozyten spezifischem apm1 und biallelische marker davon - Google Patents

Genomische und vollständige cdna sequenzen von menschlichem adipozyten spezifischem apm1 und biallelische marker davon

Info

Publication number
ATE397064T1
ATE397064T1 AT99954295T AT99954295T ATE397064T1 AT E397064 T1 ATE397064 T1 AT E397064T1 AT 99954295 T AT99954295 T AT 99954295T AT 99954295 T AT99954295 T AT 99954295T AT E397064 T1 ATE397064 T1 AT E397064T1
Authority
AT
Austria
Prior art keywords
apm1
biallelic markers
genomic
provides
biallelic
Prior art date
Application number
AT99954295T
Other languages
English (en)
Inventor
Isabelle Dufaure-Gare
Lydie Bougueleret
Marta Blumenfeld
Bernard Bihain
Original Assignee
Serono Genetics Inst Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Genetics Inst Sa filed Critical Serono Genetics Inst Sa
Application granted granted Critical
Publication of ATE397064T1 publication Critical patent/ATE397064T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/928—X-ray agent

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT99954295T 1998-11-04 1999-11-04 Genomische und vollständige cdna sequenzen von menschlichem adipozyten spezifischem apm1 und biallelische marker davon ATE397064T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10711398P 1998-11-04 1998-11-04
US11959399P 1999-02-10 1999-02-10

Publications (1)

Publication Number Publication Date
ATE397064T1 true ATE397064T1 (de) 2008-06-15

Family

ID=26804398

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99954295T ATE397064T1 (de) 1998-11-04 1999-11-04 Genomische und vollständige cdna sequenzen von menschlichem adipozyten spezifischem apm1 und biallelische marker davon

Country Status (9)

Country Link
US (3) US6582909B1 (de)
EP (1) EP1127120B1 (de)
JP (1) JP2002528118A (de)
AT (1) ATE397064T1 (de)
AU (1) AU772243B2 (de)
CA (1) CA2348828C (de)
DE (1) DE69938837D1 (de)
ES (1) ES2308852T3 (de)
WO (1) WO2000026363A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040048265A1 (en) * 2000-07-18 2004-03-11 Daniel Cohen Obesity associated biallelic marker maps
US6829589B1 (en) 2000-07-21 2004-12-07 Stc, Llc Method and apparatus for stock and index option price improvement, participation, and internalization
JP2005535561A (ja) * 2002-01-18 2005-11-24 プロテミックス コーポレイション リミティド アディポネクチンのグリコアイソフォームとその使用
EP1577388B1 (de) 2002-12-26 2011-02-16 Ono Pharmaceutical Co., Ltd. Adiponectin-promoter und verwendung davon
DK2264170T3 (en) 2003-05-21 2017-03-20 Andes Biotechnologies S A Markers for precancerous cells and cancer cells and methods for disrupting the proliferation of such cells
WO2005013091A2 (en) * 2003-08-01 2005-02-10 New York University Methods, software arrangements, storage media, and systems for genotyping or haplotyping polymorphic genetic loci or strain identification
JP4742032B2 (ja) 2004-03-31 2011-08-10 株式会社東京大学Ｔｌｏ アディポネクチン発現誘導剤およびその利用
WO2006062422A1 (en) * 2004-12-10 2006-06-15 Protemix Corporation Limited Glyponectin (glycosylated adiponectin) for the treatment of diseases and conditions
US8685642B2 (en) * 2007-07-30 2014-04-01 Agilent Technologies, Inc. Allele-specific copy number measurement using single nucleotide polymorphism and DNA arrays
CN111269978B (zh) * 2020-03-27 2020-12-08 深圳市天大生物医疗器械有限公司 一种人ApoE基因分型检测试剂盒

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
DE3924454A1 (de) * 1989-07-24 1991-02-07 Cornelis P Prof Dr Hollenberg Die anwendung von dna und dna-technologie fuer die konstruktion von netzwerken zur verwendung in der chip-konstruktion und chip-produktion (dna chips)
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5270170A (en) 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
US6140466A (en) 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
US5691447A (en) 1995-03-24 1997-11-25 Tanox Biosystems, Inc. GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
FR2733762B1 (fr) 1995-05-02 1997-08-01 Genset Sa Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm et preparation d'arnm et d'adnc complet
US5869330A (en) * 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
AU731685C (en) 1996-01-23 2002-08-22 Indevus Pharmaceuticals, Inc. Methods for using the obese gene and its gene product to stimulate hematopoietic development
WO1998002157A1 (de) 1996-07-13 1998-01-22 Roche Diagnostics Gmbh Topisch einsetzbare pharmazeutische formulierungen enthaltend als wirkstoff ein carbazolyl-(4)-oxy-propanolamin-derivat
WO1998020165A2 (en) 1996-11-06 1998-05-14 Whitehead Institute For Biomedical Research Biallelic markers
FR2767135B1 (fr) * 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
CA2301660A1 (en) * 1997-08-26 1999-03-04 Zymogenetics, Inc. Adipocyte-specific protein homologs
JP3538711B2 (ja) * 1997-10-29 2004-06-14 大塚製薬株式会社 平滑筋増殖抑制組成物、動脈硬化症診断方法及びそのキット
US7338787B2 (en) * 2000-01-14 2008-03-04 Serono Genetics Institute S.A. Nucleic acids encoding OBG3 globular head and uses thereof
US6566332B2 (en) * 2000-01-14 2003-05-20 Genset S.A. OBG3 globular head and uses thereof for decreasing body mass
US6989367B2 (en) * 2000-01-14 2006-01-24 Genset S.A. OBG3 globular head and uses thereof
US6579852B2 (en) * 2000-01-14 2003-06-17 Genset S.A. OBG3 globular head and uses thereof for decreasing body mass
US20020058617A1 (en) * 2000-01-14 2002-05-16 Joachim Fruebis OBG3 globular head and uses thereof for decreasing body mass

Also Published As

Publication number Publication date
US6582909B1 (en) 2003-06-24
ES2308852T3 (es) 2008-12-01
CA2348828A1 (en) 2000-05-11
AU772243B2 (en) 2004-04-22
US20030165967A1 (en) 2003-09-04
WO2000026363A1 (en) 2000-05-11
JP2002528118A (ja) 2002-09-03
DE69938837D1 (de) 2008-07-10
US20060166259A1 (en) 2006-07-27
EP1127120A1 (de) 2001-08-29
AU1070300A (en) 2000-05-22
EP1127120B1 (de) 2008-05-28
CA2348828C (en) 2009-09-15

Similar Documents

Publication Publication Date Title
ATE236998T1 (de) Prostatakrebs-gen
ATE266737T1 (de) Künstliche fehlhybridisierung
WO1998020165A3 (en) Biallelic markers
Hayward et al. A novel mutation in the fibrillin gene (FBN1) in familial arachnodactyly
DE69938837D1 (de) Genomische und vollständige cdna sequenzen von menschlichem adipozyten spezifischem apm1 und biallelische marker davon
WO2001000803A3 (en) Apolipoprotein a-iv-related protein: polypeptide, polynucleotide sequences and biallelic markers thereof
ATE427362T1 (de) Polymorphe marker des lsr-gens
WO2004044163A3 (en) Methods for identifying risk of melanoma and treatments thereof
Lee et al. Polymorphism in the mitochondrial cytochrome B gene in Koreans: an additional marker for individual identification
WO2001066800A8 (en) Human single nucleotide polymorphisms
WO2001051659A3 (en) Biallelic markers derived from genomic regions carrying genes involved in central nervous system disorders
DE69816467D1 (de) Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung
WO1999050454A3 (en) Coding sequence polymorphisms in vascular pathology genes
WO1999054500A3 (en) Biallelic markers for use in constructing a high density disequilibrium map of the human genome
WO2003018746A3 (en) Estrogen receptor alpha variants and methods of detection thereof
WO2000058519A3 (en) Charaterization of single nucleotide polymorphisms in coding regions of human genes
ATE408025T1 (de) Biallelische marker die im zusammenhang stehen mit medikamentenmetabolismus beteiligten genen
ATE213279T1 (de) Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismus
EP1262565A3 (de) Genetische Polymorphismen im menschlichen neurokinin 1 Rezeptoren Gen und ihren Verwendungen zur Diagnose und Behandlung der Krankheiten
WO2001042511A3 (en) Ibd-related polymorphisms
WO1999053095A3 (en) Biallelic markers
Charmley et al. Polymorphism detection and sequence analysis of human T-cell receptor V α-chain-encoding gene segments
WO2001062969A3 (en) Estrogen receptor alpha variants and methods of detection thereof
WO2001038576A3 (en) Human single nucleotide polymorphisms
WO2003020980A3 (en) Single nucleotide polymorphisms diagnostic for schizophrenia

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties